[1] Poggiogalle E, Donini LM, Lenzi A, et al.Non-alcoholic fatty liver disease connections with fat-free tissues: A focus on bone and skeletal muscle. World J Gastroenterol,2017,23:1747-1757.
[2] Tanaka KI, Xue Y, Nguyen-Yamamoto L,et al.FAM210A is a novel determinant of bone and muscle structure and strength. Proc Natl Acad Sci USA,2018,115:E3759-E3768.
[3] Filip R, Radzki RP, Bieńko M. Novel insights into the relationship between nonalcoholic fatty liver disease and osteoporosis. Clin Interv Aging,2018,13:1879-1891.
[4] Eshraghian A.Bone metabolism in non-alcoholic fatty liver disease: vitamin D status and bone mineral density. Minerva Endocrinol, 2017,42:164-172.
[5] De Bandt JP, Jegatheesan P, Tennoune-El-Hafaia N.Muscle Loss in Chronic Liver Diseases: The Example of Nonalcoholic Liver Disease. Nutrients,2018,10. pii: E1195.
[6] Bhanji RA, Narayanan P, Allen AM, et al. Sarcopenia in hiding: The risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis. Hepatology,2017,66:2055-2065.
[7] Dasarathy S. Cause and management of muscle wasting in chronic liver disease. Curr Opin Gastroenterol,2016,32:159-165.
[8] Ticinesi A, Lauretani F, Milani C, et al.Aging gut microbiota at the cross-road between nutrition, physical frailty, and sarcopenia: Is there a gut-muscle axis? Nutrients,2017,9. pii: E1303.
[9] Chen DZ, Xu QM, Wu XX, et al. The combined effect of nonalcoholic fatty liver disease and metabolic syndrome on osteoporosis in postmenopausal females in Eastern China. Int J Endocrinol,2018,2018:2314769.
[10] Chen HJ, Yang HY, Hsueh KC, et al. Increased risk of osteoporosis in patients with nonalcoholic fatty liver disease: A population-based retrospective cohort study.Medicine (Baltimore),2018,97:e12835.
[11] Ahn SH, Seo DH, Kim SH, et al.The relationship between fatty liver index and bone mineral density in Koreans: KNHANES 2010-2011. Osteoporos Int. 2018,29:181-190.
[12] Kim G, Kim KJ,Rhee Y,et al. Significant liver fibrosis assessed using liver transient elastography is independently associated with low bone mineral density in patients with nonalcoholic fatty liver disease. PLoS One,2017,12:e0182202
[13] Hashimoto Y, Osaka T, Fukuda T, et al. The relationship between hepatic steatosis and skeletal muscle mass index in men with type 2 diabetes. Endocr J,2016,63:877-884.
[14] Koo BK, Kim D, Joo SK,et al. Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis. J Hepatol, 2017,66:123-131.
[15] Petta S, Ciminnisi S, Di Marco V, et al. Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther,2017,45:510-518.
[16] Kim G, Lee SE, Lee YB, et al.Relationship Between Relative Skeletal Muscle Mass and Nonalcoholic Fatty Liver Disease: A 7-Year Longitudinal Study.Hepatology,2018,68:1755-1768.
[17] Miljkovic I, Kuipers AL, Cauley JA,et al. Greater Skeletal Muscle Fat Infiltration Is Associated With Higher All-Cause and Cardiovascular Mortality in Older Men. J Gerontol A Biol Sci Med Sci, 2015,70:1133-1140.
[18] Adams LA, Anstee QM, Tilg H,et al.Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases.Gut,2017,66:1138-1153.
[19] Watanabe S, Kawamoto S, Ohtani N, et al. Impact of senescence-associated secretory phenotype and its potential as a therapeutic target for senescence-associated diseases. Cancer Sci,2017,108:563-569.
[20] Zhai Y, Xiao Q.The Common Mechanisms of Sarcopenia and NAFLD.Biomed Res Int,2017,2017:6297651.
[21] Compston J, Cooper A, Cooper C,et al.UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos, 2017,12(1):43. |
